Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis
about
Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFsMolecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily membersMolecular mechanisms of fibroblast growth factor signaling in physiology and pathologyFibroblast growth factors share binding sites in heparan sulphate.Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis.Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities.Heparin-binding domains in vascular biology.Heparin binding preference and structures in the fibroblast growth factor family parallel their evolutionary diversification.The structural biology of the FGF19 subfamilyDual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesisSelecting antagonistic antibodies that control differentiation through inducible expression in embryonic stem cells.Transcriptional targets of Foxd3 in murine ES cells.Constructing stem cell microenvironments using bioengineering approaches.6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture.Influence of heparin mimetics on assembly of the FGF.FGFR4 signaling complex.Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries.Fractone-heparan sulphates mediate FGF-2 stimulation of cell proliferation in the adult subventricular zone.Cell number and chondrogenesis in human mesenchymal stem cell aggregates is affected by the sulfation level of heparin used as a cell coating.Multimers of the fibroblast growth factor (FGF)-FGF receptor-saccharide complex are formed on long oligomers of heparin.Generation of aminoterminally truncated, stable types of bioactive bovine and porcine fibroblast growth factor 4 in Escherichia coli.CAR T-cell immunotherapy of MET-expressing malignant mesothelioma.Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys.Combination of Heparin Binding Peptide and Heparin Cell Surface Coatings for Mesenchymal Stem Cell Spheroid Assembly.
P2860
Q24305543-8571CD28-2FF0-4D4F-87EC-07BFF06097D2Q24683254-1601C790-A359-43C2-BC52-4AA678F2E286Q28291993-39AD05AB-EEB9-4155-ACCE-F54D3509E027Q31153852-5E2143A1-B1B5-4793-8F01-0E8DBEFD8901Q33910462-FEB29882-A463-409E-8B40-0821FF59BF47Q34074836-54FA7D62-C882-48E4-826D-9FCBB6D13138Q35825233-A90C2055-6DBF-496A-91F7-89CDB0D05474Q35974633-B534DB6F-3AF9-409F-9FD1-8F356CF3DA6CQ36928572-5316E5DF-AF15-4E4A-A880-D533E8B2A132Q37265743-9A818C55-D104-4587-8B3D-C6256A72E96EQ37276749-B33A3807-0C3A-4A96-9EF1-9D4C42B86D6CQ37602534-39B5E998-AB7F-4D83-A44E-BDB801533F73Q38142559-04499E5E-6155-4468-B4F8-7B1B1A3D9C05Q38293479-139DEBC9-EBAD-423E-B116-158BE1D8AD33Q38343318-B2A09BFD-419C-4B5E-87A0-A314F748C523Q38528036-4BCD51AF-0C44-4987-9892-D9DEC3D0763FQ38977037-B9493445-2DD6-4976-9120-C54D08A07EAEQ41160345-55A6C496-A12C-4B24-BE07-03DF453C238DQ43197470-C7E4496F-1659-44A8-89B9-E56ECFE44B3FQ44482322-2924355A-B7D9-4136-B6AB-76A9E3CFC585Q47280088-72518697-6E8A-4A59-9812-718EDC56A2B1Q47312274-5645A3D5-DC1B-43CE-BFB2-9F3F944513B2Q50005301-F46B54D7-011C-487A-8B3E-27090251ACDA
P2860
Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Identification of receptor and ...... by structure-based mutagenesis
@ast
Identification of receptor and ...... by structure-based mutagenesis
@en
Identification of receptor and ...... by structure-based mutagenesis
@nl
type
label
Identification of receptor and ...... by structure-based mutagenesis
@ast
Identification of receptor and ...... by structure-based mutagenesis
@en
Identification of receptor and ...... by structure-based mutagenesis
@nl
altLabel
Identification of Receptor and ...... by Structure-Based Mutagenesis
@en
prefLabel
Identification of receptor and ...... by structure-based mutagenesis
@ast
Identification of receptor and ...... by structure-based mutagenesis
@en
Identification of receptor and ...... by structure-based mutagenesis
@nl
P2093
P2860
P3181
P1476
Identification of receptor and ...... by structure-based mutagenesis
@en
P2093
A N Plotnikov
A V Eliseenkova
C Basilico
M Mohammadi
P2860
P304
P3181
P356
10.1128/MCB.21.17.5946-5957.2001
P407
P577
2001-09-01T00:00:00Z